CLINICAL_TRIALS
trial_result
· 2021-02-11
Clinical Trial Update: A Study of HX008 for the Treatment of Patients With Malignant Melanoma [Phase 2]
Summary
Phase 2 clinical trial update for HX008 in malignant melanoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taizhou Hanzhong biomedical co. LTD | Conditions: Melanoma | Phase 2 | Status: UNKNOWN